We have demonstrated that these TAMs, which arise from circulating monocytes that are recruited into the tumor microenvironment [35], can be modulated by the gCSCs by inducing an immunosuppressive phenotype via the STAT3 pathway[4]. Here, STAT3 is linked to neoplasm.